Outer Biosciences Leverages Live Tissue and AI for Skincare Research

Industry Pulse News Desk · 2026-08-24

Outer Biosciences co-founders Michael Polansky and Lady Gaga are utilizing live skin tissue samples and artificial intelligence to discover new beauty compounds.

Outer Biosciences, a biotechnology firm co-founded by tech entrepreneur Michael Polansky and recording artist Lady Gaga, is leveraging live human tissue samples and artificial intelligence to develop next-generation skincare compounds for the global beauty industry.

The enterprise focuses on utilizing viable skin tissue obtained from elective surgical procedures to analyze cellular responses to various molecular formulations. By integrating these biological models with advanced machine learning algorithms, the platform can predict how active ingredients interact with human skin at a microscopic level.

Traditional dermatological research frequently relies on synthetic tissue substitutes, static cell cultures, or animal testing. Outer Biosciences aims to modernize this process by measuring real-time biological data directly from living human skin cells, enabling researchers to evaluate ingredient safety and functional efficacy with greater accuracy before initiating commercial formulation.

Polansky and Lady Gaga established the venture to bridge advanced biomedical research with consumer personal care products. The company's underlying computational platform processes proprietary datasets that track transcriptomic and structural changes in skin tissue when exposed to prospective active ingredients.

The development comes as the global skincare market sees increased demand for scientifically backed dermatological products and precise therapeutic formulations. Outer Biosciences has not yet disclosed specific financial terms or a targeted commercial launch date for its initial product pipeline.